“…Since then, four silk-based biomedical materials have been commercialized, including bioresorbable surgical mesh (SERI Surgical Scaffold ® ) [ 22 ], silk fabric (MICROAIR DermaSilk ® ) for atopic dermatitis in children [ 23 , 24 ], a silk patch (Tympasil) for acute tympanic membrane perforation treatment [ 25 ], and a silk fibroin wound dressing (Sidaiyi) [ 26 ]. With its superior biocompatibility, controllable biodegradation into noninflammatory byproducts, aqueous processibility, compatibility with sterilization, robust mechanical and thermal properties, and sufficient supply, silk has become a popular biomaterial for drug delivery, as a biosensor, and for tissue engineering [ 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 ]. It has been shown that silk is able to encapsulate a variety of molecules, including protein HIV inhibitors, antibodies, and small molecules, with multiple modalities such as 3D porous scaffolds, films, gels, particulates, and microneedle patches, contributing a desired drug delivery system as a microbicide [ 38 , 39 , 40 , 41 ].…”